Antithrombotic
Source: Wikipedia, the free encyclopedia.
Drug that reduces the formation of blood clots
An antithrombotic agent is a drug that reduces the formation of blood clots (
clinical guidelines for clinicians for the use of these drugs to treat and prevent a variety of diseases.[citation needed
]
Processes
Different antithrombotics affect different blood clotting processes:
- Antiplatelet drugs limit the migration or aggregation of platelets.
- Anticoagulants limit the ability of the blood to clot.
- Thrombolytic drugsact to dissolve clots after they have formed.
See also
- Direct Xa inhibitor
- Warfarin
References
External links
- Antithrombotic Therapy / American Society of Hematology
Antiplatelet drugs |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
) | |||||||||||||||
Factor Xa inhibitors (with some II inhibition) |
| ||||||||||||||
Direct thrombin (IIa) inhibitors |
| ||||||||||||||
Other |
fibrinolytics
- r-tPA
- UPA
- Anistreplase
- Monteplase
- Streptokinase#
- Other serine endopeptidases: Ancrod‡
- Brinase
- Fibrinolysin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |